Sialic Acid Binding Liposome Nanoparticles for Targeted Bladder Cancer Therapy
ACS Biomaterials Science & Engineering · 09.02.2026 · 12 (2) · 971-985
DOI: 10.1021/acsbiomaterials.5c01546 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 07.01.2026. Verfasst von Xiaodi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Liposomes, Nanoparticles, N-Acetylneuraminic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Kansas.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
- Bioengineering Program, University of Kansas, Lawrence, Kansas 66047, United States.
ORCID-Profile: Su Jeong Song, Hyunjoon Kim
Förderung
- NIGMS NIH HHS
- University of Kansas
Zitieren
APA
Li, X., Xie, J., Song, S. J., Ahlquist, C. S. E., & Kim, H. (2026). Sialic Acid Binding Liposome Nanoparticles for Targeted Bladder Cancer Therapy. ACS Biomaterials Science & Engineering, 12(2), 971-985. https://doi.org/10.1021/acsbiomaterials.5c01546
Vancouver
Li X, Xie J, Song SJ, Ahlquist CSE, Kim H. Sialic Acid Binding Liposome Nanoparticles for Targeted Bladder Cancer Therapy. ACS Biomaterials Science & Engineering. 2026;12(2):971-985. doi:10.1021/acsbiomaterials.5c01546
BibTeX
@article{Li2026,
author = {Li, Xiaodi and Xie, Jin and Song, Su Jeong and Ahlquist, Connor S E and Kim, Hyunjoon},
title = {Sialic Acid Binding Liposome Nanoparticles for Targeted Bladder Cancer Therapy},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
volume = {12},
number = {2},
pages = {971--985},
doi = {10.1021/acsbiomaterials.5c01546}
}
EUVIMED